Michael Frederick Bahntge is a Cleveland, Ohio based neurologist with 45 years of experience in Neurology. He completed his graduation from State University Of New York Downstate Medical Center in 1979. He is also affiliated with hospitals like and . He accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Michael Frederick Bahntge is 35048477B for Neurology in Ohio. His current practice location is 2500 Metrohealth Dr, Cleveland. Patients can reach him at 216-778-3958. Michael Frederick Bahntge is MD in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1740256064. Michael Frederick Bahntge specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Michael Frederick Bahntge speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Michael Frederick Bahntge
Specialization:
Neurology
Gender:
Male
Credentials:
MD
Experience:
45+ years
Medical School Attended:
State University Of New York Downstate Medical Center
Graduation Year:
1979
Accepts Medicare Assignment:
Yes
Practice Address:
2500 Metrohealth Dr, Cleveland, Ohio, 44109-1900
Phone:
216-778-3958
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
8628095981
Enrollment ID:
I20051027000010
NPI Number:
1740256064
NPI Enumeration Date:
27 Feb, 2006
NPI Last Update On:
23 Sep, 2018
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Michael Frederick Bahntge are as mentioned below.
License Number
Specialization
State
Status
35048477B
Neurology
Ohio
Primary
Hospital Affiliation:
Surgeons are affiliated to many hospitals whom they worked with in the past or are presently working with. One surgeon can be affiliated to four to five hospitals at a time.
Hospital Name (CCN)
State
Hospital Type
(360180)
Cleveland, OH
Acute Care Hospital
(360364)
Avon, OH
Acute Care Hospital
(360077)
Cleveland, OH
Acute Care Hospital
Group Practice:
Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name
with which Michael Frederick Bahntge is associated with along with the number of members in that group.
Organization Name (Group PAC ID)
Members
Cleveland Clinic Foundation (1850203555)
5185
Other Medical Identifiers:
Other legacy medical identifiers associated with Michael Frederick Bahntge such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
11046868
Other
CAQH
CA4511
Other
RR MEDICARE GROUP
D368301
Other
GROUP IND DIAGNOSTICS MED
9273172
Other
GROUP MEDICARE
0119204
Other
GROUP MEDICAID
0587931
Medicaid
Ohio
1780634279
Other
GROUPNPI
4326122
Other
AETNA
CA4511
Other
GROUP RR MEDICARE
000000276513
Other
ANTHEM
0501231
Other
UNITED HEALTHCARE
341783789031
Other
CARESOURCE
C78477
Other
SUMMACARE APEX
3610861
Other
GROUP ASC MEDICARE
103647
Other
KAISER
130026262
Other
RR MEDICARE INDIVIDUAL
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Michael Frederick Bahntge 20525 Center Ridge Rd, Ste 220 Rocky River, Ohio
Zip:
44116
Phone Number:
440-895-5056
Fax Number:
440-333-2935
Patients can reach Michael Frederick Bahntge at 2500 Metrohealth Dr, Cleveland, Ohio or can call to book an appointment on 216-778-3958.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.